Additional information
| Active substance | Onabotulinumtoxina |
|---|---|
| Classification | Botulinum toxin type A |
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Mouse bioassay for potency testing |
| Also known as | Botox, onabotulinumtoxinA |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | No significant effect |
| Trade name | Botox, Dysport, Xeomin |
| Storage conditions | Refrigerated, 2-8В°C |
| Chemical name | Botulinum toxin type A |
| Formula | C6760H10447N1743O2010S32 |
| Substance class | Neurotoxin |
| Main action | Blocks the release of acetylcholine at neuromuscular junctions |
| Half-life | 2-6 months |
| Dosage (medical) | 20-100 units injected intramuscularly, depending on treatment area |
| Dosage (sports) | Not applicable |
| Effects | Reduces muscle activity, treats wrinkles, muscle spasms, and excessive sweating |
| Side effects | Pain at injection site, headache, muscle weakness, drooping eyelids, dysphagia, spread of toxin effects |
| Use in sports | None, usage in sports would be considered misuse |
| Manufacturer | Allergan |
Champix 56 tabs Pfizer
Tavanic 500 mg Sanofi
Muscoflex 8 mg Bilim
Clenbuterol 0,02mg Sterling Knight
Norvacs 5 mg Pfizer
Champix Starter Pack Pfizer
Fostimon (Merional) 75 (HMG) IBSA
HALOROW cRowX Labs
Cialis Tadalafil 20 mg 30 Tabletten
Dihexa Spectre Labs
Spiriva HandiHaler 18mg Boehringer Ingelheim 

Reviews
There are no reviews yet.